RxDoctor Payments Data

Max Baldwin, PA

Family Medicine · Lafayette, GANPI 1316028467

Payments from drug & device makers

$3,041in general payments, 2019–2025

Across 161 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$533
  • Lilly USA, LLC$250
  • Pfizer$243
  • Xeris Pharmaceuticals, Inc.$187
  • AstraZeneca$174
  • Novo Nordisk$164
  • plus $1K from 30 others

What the payments were for

  • Food & beverage$3,041100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,041 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$80,659
Medicare patients
205
Services billed
2,429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban198$142,572
OzempicSemaglutide71$98,803
FarxigaDapagliflozin Propanediol92$72,583
Trelegy ElliptaFluticasone/Umeclidin/Vilanter88$60,320
MounjaroTirzepatide50$59,884
JanuviaSitagliptin Phosphate37$45,066
LinzessLinaclotide77$43,593
JardianceEmpagliflozin34$36,486
Breztri AerosphereBudesonide/Glycopyr/Formoterol27$22,686
XareltoRivaroxaban22$21,356
Breo ElliptaFluticasone/Vilanterol46$18,854
EntrestoSacubitril/Valsartan29$18,607
Soliqua 100-33Insulin Glargine/Lixisenatide18$17,179
Janumet XrSitagliptin Phos/Metformin Hcl17$16,883
Combivent RespimatIpratropium/Albuterol Sulfate20$16,786

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$243$149,281210 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$174$99,381138 claims
Novo NordiskOzempic$164$98,80371 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta$123$94,843169 claims
MerckJanuvia, Janumet Xr, Janumet$30$71,27067 claims
Lilly USA, LLCMounjaro$250$59,88450 claims
AbbVieLinzess, Ubrelvy$533$54,27988 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$46$21,06139 claims
Otsuka America Pharmaceutical, Inc.Rexulti$109$16,15711 claims
Astellas Pharma US IncMyrbetriq$92$10,91518 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$34$8,30718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Lafayette

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →